Showing results (11-20 of 158) with videos related to
Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|December 14, 2004
Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma GroupIan Judson, Peiming Ma, Bin Peng, et al.Gynecologic Oncology Reports|December 28, 2020
Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literatureIan Judson, Christina MessiouArchives of Toxicology|July 1, 2011
The safety profile of imatinib in CML and GIST: long-term considerationsEirini Thanopoulou, Ian JudsonExpert Review of Anticancer Therapy|August 1, 2012
Hormonal therapy in gynecological sarcomasEirini Thanopoulou, Ian JudsonExpert Review of Anticancer Therapy|February 6, 2010
Role of chemotherapy in the management of soft tissue sarcomasDimitrios Krikelis, Ian JudsonEuropean Journal of Cancer (Oxford, England : 1990)|May 27, 2014
Role of expert centres in the management of sarcomas--a UK perspectiveCharlotte Benson, Ian JudsonAnnals of Surgical Oncology|May 5, 2004
Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapyBurton L Eisenberg, Ian JudsonExpert Opinion on Drug Safety|August 14, 2013
Safety evaluation of trabectedin in treatment of soft-tissue sarcomasJuan Martin-Liberal, Ian JudsonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignanciesUdai Banerji, Anne O'Donnell, Michelle Scurr, et al.Current Cancer Drug Targets|October 8, 2003
The clinical applications of heat shock protein inhibitors in cancer - present and futureUdai Banerji, Ian Judson, Paul WorkmanPageof 16